Sunshine Biopharma (SBFM) EBIT (2011 - 2026)
Sunshine Biopharma (SBFM) posted EBIT of -$1.4 million for Q1 2026, up 22.03% on a QoQ basis from -$1.8 million in Q4 2025, and down 7.71% year-over-year from -$1.5 million in Q1 2025.
Sunshine Biopharma (SBFM) EBIT (2011 - 2026) Analysis & Trends
Sunshine Biopharma's EBIT history runs 15 years deep, the most recent figure standing at -$1.4 million for Q1 2026.
- Quarterly EBIT fell 7.71% year-over-year to -$1.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$6.3 million (down 10.84% YoY) and the FY2025 annual result came in at -$6.2 million, down 7.14% from the prior year.
- EBIT was -$1.4 million for Q1 2026 at Sunshine Biopharma, up from -$1.8 million in the prior quarter.
- Across five years, EBIT topped out at -$695796.0 in Q2 2022 and bottomed at -$23.4 million in Q4 2022.
- A 5-year average of -$2.7 million and a median of -$1.3 million in 2025 frame the typical range for EBIT.
- Annual changes were most pronounced in 2022 — EBIT slumped 8255.16% — and 2023, when it soared 94.92%.
- Sunshine Biopharma's EBIT stood at -$23.4 million in 2022, then surged by 94.92% to -$1.2 million in 2023, then slumped by 71.64% to -$2.0 million in 2024, then rose by 12.16% to -$1.8 million in 2025, then advanced by 22.03% to -$1.4 million in 2026.
- Business Quant data shows SBFM's EBIT at -$1.4 million in Q1 2026, -$1.8 million in Q4 2025, and -$1.1 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.28 Bn | 87.42 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.97 Bn | 32.23 Bn | 1.97 Bn | 652.00 Mn |
| 3 | Zoetis | 32.42 Bn | 30.48 Bn | 1.62 Bn | 833.00 Mn |
| 4 | Takeda Pharmaceutical | 27.48 Bn | 23.42 Bn | 4.39 Bn | -2.65 Bn |
| 5 | United Therapeutics | 22.89 Bn | 20.73 Bn | 648.10 Mn | 325.80 Mn |
| 6 | RedHill Biopharma | 22.11 Bn | 22.11 Bn | - | - |
| 7 | Viatris | 20.44 Bn | 18.64 Bn | 1.16 Bn | -79.70 Mn |
| 8 | Neurocrine Biosciences | 17.76 Bn | 16.44 Bn | 800.70 Mn | 193.40 Mn |
| 9 | Elanco Animal Health | 12.62 Bn | 12.19 Bn | 785.00 Mn | 291.00 Mn |
| 10 | Sunshine Biopharma | 750,608.81 | -6.16 Mn | 2.18 Mn | -1.40 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1.40 Mn |
| Dec 31, 2025 | -1.79 Mn |
| Sep 30, 2025 | -1.09 Mn |
| Jun 30, 2025 | -2.05 Mn |
| Mar 31, 2025 | -1.30 Mn |
| Dec 31, 2024 | -2.04 Mn |
| Sep 30, 2024 | -1.11 Mn |
| Jun 30, 2024 | -1.27 Mn |
| Mar 31, 2024 | -1.35 Mn |
| Dec 31, 2023 | -1.19 Mn |
| Sep 30, 2023 | -779,474.00 |
| Jun 30, 2023 | -1.01 Mn |
| Mar 31, 2023 | -1.83 Mn |
| Dec 31, 2022 | -23.36 Mn |
| Sep 30, 2022 | -1.72 Mn |
| Jun 30, 2022 | -695,796.00 |
| Mar 31, 2022 | -1.22 Mn |
| Dec 31, 2021 | -279,631.00 |
| Sep 30, 2021 | -496,259.00 |
| Jun 30, 2021 | -388,598.00 |